"（%）","（%）","（%）","（%）","（%）","（%）","（%）"
"减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点","减少生物制药134591377.0029864436.3277.81-57.74-40.976.31个百分点"
"主营业务分产品情况","主营业务分产品情况","主营业务分产品情况","主营业务分产品情况","主营业务分产品情况","主营业务分产品情况","主营业务分产品情况"
"分产品","营业收入","营业成本","毛利率（%）","营业收入比上年增减（%）","营业成本比上年增减（%）","毛利率比上年增减（%）"
"四价流感病毒裂解疫苗","134591377.00","29864436.32","77.81","-57.74","-40.97","减少6.31个百分点"
"主营业务分地区情况","主营业务分地区情况","主营业务分地区情况","主营业务分地区情况","主营业务分地区情况","主营业务分地区情况","主营业务分地区情况"
"分地区","营业收入","营业成本","毛利率（%）","营业收入比上年增减（%）","营业成本比上年增减（%）","毛利率比上年增减（%）"
"国内","134591377.00","29864436.32","77.81","-57.74","-40.97","减少6.31个百分点"
"主营业务分销售模式情况","主营业务分销售模式情况","主营业务分销售模式情况","主营业务分销售模式情况","主营业务分销售模式情况","主营业务分销售模式情况","主营业务分销售模式情况"
"销售模式","营业收入","营业成本","毛利率（%）","营业收入比上年增减（%）","营业成本比上年增减（%）","毛利率比上年增减（%）"
"直销","134591377.00","29864436.32","77.81","-57.74","-40.97","减少6.31个百分点"